ANIX - Anixa Biosciences

-

$undefined

N/A

(N/A)

Anixa Biosciences NASDAQ:ANIX Anixa Biosciences Inc. is a biotechnology company developing a number of programs addressing cancer and infectious disease. Anixa's therapeutics portfolio includes a cancer immunotherapy program which uses a novel type of CAR-T, known as chimeric endocrine receptor T-cell (CER-T) technology, and a Covid-19 therapeutics program focused on inhibiting certain viral protein function. The company's vaccine portfolio includes a vaccine to prevent breast cancer, and specifically triple negative breast cancer (TNBC), the most deadly form of the disease, and a vaccine to prevent ovarian cancer. These vaccine technologies focus on immunizing against specific proteins that have been found to be expressed in certain forms of cancer. Anixa continually examines emerging technologies in complementary fields for further development and commercialization.

Location: 3150 Almaden Expy Ste 250, California, 95118, US | Website: www.anixa.com | Industry: Computer Storage Device Manufacturing | Sector: Manufacturing


Market Cap

NaN

52 Wk Range

$ - $

Previous Close

$N/A

Open

$N/A

Day Range

N/A - N/A

Volume

N/A

Avg Volume

N/A

Enterprise Value

82.67M

Cash

20.75M

Avg Qtr Burn

-2.094M

Short % of Float

1.35%

Insider Ownership

5.05%

Institutional Own.

17.46%

Qtr Updated

07/31/24